These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31267590)

  • 1. Securing the Payload, Finding the Cell, and Avoiding the Endosome: Peptide-Targeted, Fusogenic Porous Silicon Nanoparticles for Delivery of siRNA.
    Kim B; Sun S; Varner JA; Howell SB; Ruoslahti E; Sailor MJ
    Adv Mater; 2019 Aug; 31(35):e1902952. PubMed ID: 31267590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy.
    Bertucci A; Kim KH; Kang J; Zuidema JM; Lee SH; Kwon EJ; Kim D; Howell SB; Ricci F; Ruoslahti E; Jang HJ; Sailor MJ
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23926-23937. PubMed ID: 31251556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery.
    Kim B; Sailor MJ
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing RNA Loading for Gene Silencing Using Porous Silicon Nanoparticles.
    Tieu T; Dhawan S; Haridas V; Butler LM; Thissen H; Cifuentes-Rius A; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):22993-23005. PubMed ID: 31252458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
    Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
    Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy.
    Wang C; Xia Y; Huo S; Shou D; Mei Q; Tang W; Li Y; Liu H; Zhou Y; Zhu B
    Int J Nanomedicine; 2020; 15():9759-9770. PubMed ID: 33304100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
    Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
    J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained small interfering RNA delivery by mesoporous silicon particles.
    Tanaka T; Mangala LS; Vivas-Mejia PE; Nieves-Alicea R; Mann AP; Mora E; Han HD; Shahzad MM; Liu X; Bhavane R; Gu J; Fakhoury JR; Chiappini C; Lu C; Matsuo K; Godin B; Stone RL; Nick AM; Lopez-Berestein G; Sood AK; Ferrari M
    Cancer Res; 2010 May; 70(9):3687-96. PubMed ID: 20430760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections.
    Kim B; Yang Q; Chan LW; Bhatia SN; Ruoslahti E; Sailor MJ
    Nanoscale Horiz; 2021 Apr; 6(4):330-340. PubMed ID: 33599221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.
    Kim B; Park JH; Sailor MJ
    Adv Mater; 2019 Dec; 31(49):e1903637. PubMed ID: 31566258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
    Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
    Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression.
    Yuan H; Huang X; Li Q; Luo C; Lin C; Zhang S; Zhang Y; Yan Z; Du N; Liu Z; Jiang H; Chen B
    Biomed Pharmacother; 2022 Mar; 147():112672. PubMed ID: 35104698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
    Bagalkot V; Gao X
    ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain.
    Kang J; Joo J; Kwon EJ; Skalak M; Hussain S; She ZG; Ruoslahti E; Bhatia SN; Sailor MJ
    Adv Mater; 2016 Sep; 28(36):7962-7969. PubMed ID: 27383373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy.
    Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T
    Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
    Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
    Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.
    Ashley CE; Carnes EC; Epler KE; Padilla DP; Phillips GK; Castillo RE; Wilkinson DC; Wilkinson BS; Burgard CA; Kalinich RM; Townson JL; Chackerian B; Willman CL; Peabody DS; Wharton W; Brinker CJ
    ACS Nano; 2012 Mar; 6(3):2174-88. PubMed ID: 22309035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.
    Cantini L; Attaway CC; Butler B; Andino LM; Sokolosky ML; Jakymiw A
    PLoS One; 2013; 8(9):e73348. PubMed ID: 24019920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.